Skip to main navigation Skip to search Skip to main content

SARS-CoV-2 infection causes dopaminergic neuron senescence

  • Liuliu Yang
  • , Tae Wan Kim
  • , Yuling Han
  • , Manoj S. Nair
  • , Oliver Harschnitz
  • , Jiajun Zhu
  • , Pengfei Wang
  • , So Yeon Koo
  • , Lauretta A. Lacko
  • , Vasuretha Chandar
  • , Yaron Bram
  • , Tuo Zhang
  • , Wei Zhang
  • , Feng He
  • , Chendong Pan
  • , Junjie Wu
  • , Yaoxing Huang
  • , Todd Evans
  • , Paul van der Valk
  • , Maarten J. Titulaer
  • Jochem K.H. Spoor, Robert L. Furler O'Brien, Marianna Bugiani, Wilma D.J. Van de Berg, Robert E. Schwartz*, David D. Ho*, Lorenz Studer*, Shuibing Chen*
*Corresponding author for this work
  • Cornell University
  • Memorial Sloan-Kettering Cancer Center
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network
  • Columbia University
  • Human Technopole Foundation
  • Amsterdam UMC
  • Vrije Universiteit Amsterdam
  • Columbia University Vagelos College of Physicians and Surgeons

Research output: Contribution to journal › Article › Academic › peer-review

77 Citations (Scopus)
240 Downloads (Pure)

Abstract

COVID-19 patients commonly present with signs of central nervous system and/or peripheral nervous system dysfunction. Here, we show that midbrain dopamine (DA) neurons derived from human pluripotent stem cells (hPSCs) are selectively susceptible and permissive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. SARS-CoV-2 infection of DA neurons triggers an inflammatory and cellular senescence response. High-throughput screening in hPSC-derived DA neurons identified several FDA-approved drugs that can rescue the cellular senescence phenotype by preventing SARS-CoV-2 infection. We also identified the inflammatory and cellular senescence signature and low levels of SARS-CoV-2 transcripts in human substantia nigra tissue of COVID-19 patients. Furthermore, we observed reduced numbers of neuromelanin+ and tyrosine-hydroxylase (TH)+ DA neurons and fibers in a cohort of severe COVID-19 patients. Our findings demonstrate that hPSC-derived DA neurons are susceptible to SARS-CoV-2, identify candidate neuroprotective drugs for COVID-19 patients, and suggest the need for careful, long-term monitoring of neurological problems in COVID-19 patients.

Original languageEnglish
Pages (from-to)196-211.e6
JournalCell Stem Cell
Volume31
Issue number2
DOIs
Publication statusPublished - 1 Feb 2024

Bibliographical note

Publisher Copyright:
© 2023 The Author(s)

Fingerprint

Dive into the research topics of 'SARS-CoV-2 infection causes dopaminergic neuron senescence'. Together they form a unique fingerprint.

Cite this